Organigram Holdings Yönetim

Yönetim kriter kontrolleri 4/4

Organigram Holdings CEO'su Beena Goldenberg, Sep2021 tarihinde atandı, in görev süresi 3.17 yıldır. in toplam yıllık tazminatı CA$ 721.58K olup, şirket hissesi ve opsiyonları dahil olmak üzere 71.5% maaş ve 28.5% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.044% ine doğrudan sahiptir ve bu hisseler € 70.01K değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 3.2 yıl ve 4.3 yıldır.

Anahtar bilgiler

Beena Goldenberg

İcra Kurulu Başkanı

CA$721.6k

Toplam tazminat

CEO maaş yüzdesi	71.5%
CEO görev süresi	3.2yrs
CEO sahipliği	0.04%
Yönetim ortalama görev süresi	3.2yrs
Yönetim Kurulu ortalama görev süresi	4.3yrs

Son yönetim güncellemeleri

Recent updates

CEO Tazminat Analizi

Beena Goldenberg'un ücretlendirmesi Organigram Holdings'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Sep 30 2023	CA$722k	CA$516k	-CA$229m
May 31 2023	n/a	n/a	-CA$222m
Feb 28 2023	n/a	n/a	-CA$11m
Nov 30 2022	n/a	n/a	-CA$8m
Aug 31 2022	CA$2m	CA$441k	-CA$14m

Tazminat ve Piyasa: Beena 'nin toplam tazminatı ($USD 516.24K ), German pazarındaki benzer büyüklükteki şirketler için ortalamanın altındadır ($USD 782.05K ).

Tazminat ve Kazançlar: Beena 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.

CEO

Beena Goldenberg (60 yo)

3.2yrs

Görev süresi

CA$721,577

Tazminat

Ms. Beena G. Goldenberg, ICD D, has been Chief Executive Officer of OrganiGram Holdings Inc. since September 9, 2021 and as its Director since November 19, 2021. Ms. Goldenberg has been Independent Directo...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Beena Goldenberg	CEO & Director	3.2yrs	CA$721.58k	0.044% € 70.0k
Helen Martin	Chief Legal Officer & Corporate Secretary	5.7yrs	CA$422.59k	0.023% € 36.2k
Timothy Emberg	Chief Commercial Officer	2.1yrs	CA$429.42k	0.022% € 35.0k
Paolo De Luca	Chief Strategy Officer	less than a year	CA$418.95k	0.023% € 36.2k
Greg Guyatt	Chief Financial Officer	less than a year	Veri yok	Veri yok
Nathalie Batten	Senior Vice President of Operations	3.4yrs	Veri yok	Veri yok
Geoff Riggs	Chief Information Officer	2.3yrs	Veri yok	Veri yok
Max Schwartz	Director of Investor Relations	no data	Veri yok	Veri yok
Megan McCrae	Senior Vice President of Marketing & Communications	3.5yrs	Veri yok	0.011% € 17.8k
Katrina McFadden	Chief People Officer	2.3yrs	Veri yok	0.015% € 23.6k
Gregory Engel	Special Advisor	3.5yrs	CA$893.95k	Veri yok
Larry Rogers	Vice President of International Business Development	7.1yrs	CA$222.73k	Veri yok

3.2yrs

Ortalama Görev Süresi

55yo

Ortalama Yaş

Deneyimli Yönetim: 0OG0 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 3.2 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Beena Goldenberg	CEO & Director	3yrs	CA$721.58k	0.044% € 70.0k
Marjorie Wieshofer	Independent Director	3.8yrs	CA$167.50k	0.0023% € 3.7k
Peter Amirault	Independent Chairman	8.4yrs	CA$236.92k	0.037% € 59.1k
Stephen Smith	Independent Director	4.8yrs	CA$176.88k	0.0024% € 3.8k
D. Machum	Independent Director	4.8yrs	CA$173.75k	0.0010% € 1.7k
Dexter D. John	Independent Director	5.9yrs	CA$180.00k	0.0014% € 2.3k
Sherry Porter	Independent Director	5.9yrs	CA$173.75k	0.0045% € 7.2k
Craig Edward Harris	Director	less than a year	Veri yok	Veri yok
Simon Ashton	Independent Director	2.8yrs	Veri yok	Veri yok
Karina Gehring	Director	less than a year	Veri yok	Veri yok

4.3yrs

Ortalama Görev Süresi

61yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 0OG0 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 4.3 yıldır).

Organigram Holdings Yönetim

Yönetim kriter kontrolleri 4/4

Anahtar bilgiler

Son yönetim güncellemeleri

Organigram Holdings Inc., Annual General Meeting, Jan 22, 2025

Organigram Announces Appointment of Craig Harris to Board of Directors

Organigram Holdings Inc. Appoints Karina Gehring as Director and Announces Composition of Committees

Organigram Holdings Inc Announces Chief Financial Officer Changes

Organigram Holdings Inc. Announces CFO Changes

Organigram Holdings Inc. Announces CFO Changes

Recent updates

Organigram Holdings Inc., Annual General Meeting, Jan 22, 2025

Organigram Holdings Inc. to Report Q3, 2024 Results on Aug 13, 2024

Organigram Announces Appointment of Craig Harris to Board of Directors

Organigram Holdings Inc. to Report Q2, 2024 Results on May 14, 2024

Organigram Holdings Inc. has completed a Composite Units Offering in the amount of CAD 25.0002 million.

Organigram Holdings Inc. Receives Health Canada’S Final Redetermination on Jolts

Organigram Holdings Inc. to Report Q1, 2024 Results on Feb 13, 2024

Organigram Holdings Inc. Appoints Karina Gehring as Director and Announces Composition of Committees

Organigram Holdings Inc Announces Chief Financial Officer Changes

Organigram Holdings Inc. to Report Q4, 2023 Results on Dec 19, 2023

Organigram Holdings Inc. Announces CFO Changes

Organigram Holdings Inc. Announces CFO Changes

Organigram Holdings Inc., Annual General Meeting, Jan 15, 2024

Organigram Holdings Inc. Announces Resignation of Ms. Caroline Ferland as Board Member

Organigram Holdings Inc. Launches First Range of THCV Products Derived from Moncton-Grown Whole Flower

Organigram Relaunches One of Canada's First Cannabis Brands, Trailblazer

Organigram Holdings Inc. Launches New Tube-style Pre-rolls: SHRED Dartz and Holy Smokes

Organigram Holdings Inc. Provides Revenue Guidance for the Fourth Quarter of 2023

Organigram Holdings Inc. to Report Q3, 2023 Results on Jul 13, 2023

Organigram Completes Share Consolidation to Ensure the Company Continues to Comply with Nasdaq Listing Requirements

Second quarter 2023 earnings released: CA$0.024 loss per share (vs CA$0.013 loss in 2Q 2022)

Organigram Holdings Receives Non-Compliance Notice from Nasdaq

First quarter 2023 earnings released: EPS: CA$0.017 (vs CA$0.004 loss in 1Q 2022)

Organigram Holdings Inc. Provides Earnings Guidance for the Second Quarter and Full Year of Fiscal 2023

Organigram Holdings Inc. to Report Q1, 2023 Results on Jan 12, 2023

Organigram Holdings Inc., Annual General Meeting, Feb 28, 2023

Full year 2022 earnings released: CA$0.046 loss per share (vs CA$0.51 loss in FY 2021)

OrganiGram Holdings Inc. Reports Impairment of Property, Plant and Equipment for the Fourth Quarter Ended August 31, 2022

Organigram Holdings Inc. Launches Holy Mountain to Further Support Its Strong Position in the Dried Flower and Hash Categories

OrganiGram Holdings Inc. to Report Q4, 2022 Results on Nov 28, 2022

High number of new directors

Forecast to breakeven in 2025

Third quarter 2022 earnings released: CA$0.009 loss per share (vs CA$0.014 loss in 3Q 2021)

OrganiGram Holdings Inc. Provides Revenue Guidance for the Fourth Quarter of Fiscal Year 2022

OrganiGram Holdings Inc. to Report Q3, 2022 Results on Jul 14, 2022

Organigram Holdings Inc. Reaches Proposed Settlement

High number of new directors

OrganiGram Holdings Inc. Provides Revenue Guidance for the Third Quarter of Fiscal Year 2022

Second quarter 2022 earnings released: CA$0.013 loss per share (vs CA$0.28 loss in 2Q 2021)

OrganiGram Holdings Inc. Reports Impairment Charges for the Second Quarter Ended February 28, 2022

OrganiGram Holdings Inc. to Report Q2, 2022 Results on Apr 12, 2022

No longer forecast to breakeven

OrganiGram Holdings Inc. Announces Board Appointments

Organigram Holdings Inc. Provides Earnings Guidance for the Second Quarter of Fiscal 2022

First quarter 2022 earnings: EPS in line with analyst expectations despite revenue beat

No longer forecast to breakeven

OrganiGram Holdings Inc. (TSX:OGI) acquired Laurentian Organic Inc. for CAD 35.9 million.

Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat

OrganiGram Holdings Inc. Provides Revenue Guidance for the First Quarter of 2022

High number of new and inexperienced directors

Organigram Holdings Inc Announces the Launch of SHRED’ems

Organigram Holdings Inc.Launches Cannabis Innovators Panel

OrganiGram Holdings Inc. Provides Revenue Guidance for the Fourth Quarter of 2021

Third quarter 2021 earnings released: CA$0.014 loss per share (vs CA$0.48 loss in 3Q 2020)

Organigram Launches Big Bag o’ Buds Indoor-grown, Strain-specific Dried Flower in 28g Value Format

Second quarter 2021 earnings released: CA$0.28 loss per share (vs CA$0.041 loss in 2Q 2020)

OrganiGram Holdings Inc. Provides Revenue Guidance for the Third Quarter of 2021

OrganiGram Holdings Inc. announced that it has received CAD 221.0736 million in funding from British American Tobacco p.l.c.

Organigram Holdings Inc. Launches SHRED Tropic Thunder Jar of J’s (Jar of Joints) and Trailblazer SNAX Milk Chocolate Bars

Senior Vice President of Operations Matt Rogers has left the company

Organigram Holdings Inc. Announces Executive Changes

New 90-day high: €1.65

Revenue misses expectations

Revenue misses expectations

First quarter 2021 earnings released: CA$0.17 loss per share

Organigram Appoints Marni Wieshofer to the Board of Directors

OrganiGram Holdings Inc. to Report Q1, 2021 Results on Jan 12, 2021

Organigram Holdings Inc. Announces the Launch of Three New Edison Cannabis Co. Indica Strains Including High Potency Black Cherry Punch and Ice Cream Cake and Full Flavour Slurricane

Organigram Launches New 1g Trailblazer Torch Vape Cartridges